CMS Measure ID:

CMS645v2

Version:

2.1.000

NQF Number:

N/A

Measure Description:

Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater (indicated by HCPCS code) and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT.

Initial Patient Population:

Male patients with a diagnosis of prostate cancer and an order for ADT that is intended for greater than or equal to12 months  during the measurement period.  Also included are male patients with a diagnosis of prostate cancer with ADT that was administered with an intent of 12 months or greater therapy and began during the measurement period.

Denominator Statement:

Equals Initial Population

Denominator Exclusions:

None

Numerator Statement:

Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment

Numerator Exclusions:

Not Applicable

Denominator Exceptions:

Patient refused recommendation for a bone density evaluation after the start of ADT therapy